Cann Group entering FY27 with ‘real momentum’, chairman says after year of financial juggling by Steve Jones August 31, 2026August 31, 2026 Cann Group has reported a normalised loss after tax of $14.7 million, a 20% improvement on […]
Cann Group ponders M&A deals, reports ‘strongest cash performance to date’ by Steve Jones July 30, 2026August 5, 2026
More funding needed by Cann Group ‘to continue its operations’ by Steve Jones April 29, 2026April 29, 2026
‘Subdued prescriber activity’ blamed by Cann Group for revenue fall by Steve Jones March 2, 2026March 5, 2026
Biortica executive quits cannabis to return to pharma sector by Steve Jones February 4, 2026February 5, 2026
Cann Group to review guidance after starting post-NAB era with ‘unexpectedly’ soft revenue by Steve Jones January 30, 2026February 3, 2026
Three cannabis firms fined by ODC for alleged licence breaches by Steve Jones December 19, 2025December 22, 2025
Cann Group set for ‘stronger future’ after ‘challenging period’, outgoing chair tells shareholders by Steve Jones December 4, 2025February 21, 2026
